Evolent Health, Inc.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical…
1D
-6.2%
1W
+13.1%
1M
+22.2%
6M
+60.9%
YTD
+14.3%
1Y
-41.4%
2Y
-82.8%
5Y
-84.7%
10Y
-81.0%
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~88% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Evolent Health provides clinical and administrative solutions for health insurers and healthcare providers in the United States. The company operates in two main segments: Evolent Health Services delivers an integrated platform for data analytics, workflow optimization, and patient engagement through its proprietary Identifi technology, enabling organizations to manage population health more efficiently. Clinical Solutions focuses on specialized case management services that help organizations transition from fee-for-service payment models to value-based care models, such as in oncology and cardiology. The goal is a comprehensive reduction of total healthcare costs.
PRICE TARGET LOW
US$7.00
CONSENSUS
US$7.00
MEDIAN
US$7.00
PRICE TARGET HIGH
US$7.00
0
STRONG BUY
23
BUY
7
HOLD
0
SELL
0
STRONG SELL
30
TOTAL · Buy
As of: 18/08/2026
P/E
-1.02
P/B
1.34
EV/EBITDA
-4.27
RETURN ON EQUITY
-7.4%
NET MARGIN
-4.3%
DEBT/EQUITY
2.53
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
91.0%
FLOAT SHARES
102,407,372
AVG. DAILY VOLUME (30D)
2,314,536
McCarthy Daniel Joseph
McCarthy Daniel Joseph
McCarthy Daniel Joseph
Blackley Seth
Blackley Seth
Register for free
Register now to see which funds are invested
Evolent Health, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Seth Barrie Blackley, the company employs around 4,200 people.
The IPO was on 05/06/2015; the stock trades on NYSE under the ticker EVH.
30 analysts rate the stock, the consensus is Buy (as of 18/08/2026).
The average price target is US$7.00, ranging from US$7.00 to US$7.00, with a median of US$7.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 88% stronger than usual.
No, Evolent Health currently does not pay a dividend.
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, SOPHiA GENETICS and Optima Health.
Clicking "Analyze stock" lets five strategies assess Evolent Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.